期刊文献+

苏州地区2010-2011年高龄孕妇孕中期产前筛查及妊娠结局 被引量:5

下载PDF
导出
摘要 目的:评价苏州地区高龄孕妇于孕中期行产前血清学二联指标筛查的可行性。方法:分析苏州市立医院2010-2011年间自愿进行孕中期血清学二联指标筛查的高龄孕妇637例,对其妊娠结局进行随访,并与这段期间低龄组(至预产期时的年龄≤35岁)进行比较。结果:筛查的高龄孕妇中,随访成功473例,其中低风险383例,唐氏综合征(Down’s syndrome,DS)高风险82例,爱德华氏综合征(Edward’s syndrome,ES)高风险6例,神经管缺陷(neural tube de-fects,NTD)高风险2例。DS高风险中确诊DS和特纳综合征各1例。NTD高风险中1例死胎。筛查低风险孕妇中1例心脏超声异常行羊水产前诊断确诊为DS。较之低风险孕妇具有更高的筛查效率。结论:苏州地区高龄孕妇行孕中期血清学二联指标筛查,筛查效率高于低龄孕妇,可以有效地提高高龄孕妇妊娠胎儿患DS的检出率,降低羊膜腔穿刺率。因此,在知情同意的基础上,对苏州地区高龄孕妇采用个体化的胎儿产前筛查和诊断策略是可行的。
出处 《南通大学学报(医学版)》 2013年第2期139-140,共2页 Journal of Nantong University(Medical sciences)
  • 相关文献

参考文献6

  • 1Nakata N, Wang Y, Bhatt S. Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age[J]. Prenat Diagn, 2010, 30(3):198-206.
  • 2戚庆炜,蒋宇林,刘俊涛,边旭明,李岩,吕时铭,朱宝生,王和,许争锋,潘小英,蔡艳.对高龄孕妇于孕中期行血清学二联指标筛查胎儿唐氏综合征的多中心前瞻性研究[J].中华妇产科杂志,2008,43(10):737-741. 被引量:69
  • 3American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 27: Clinical Management Guidelines for Obstetrician-Gynecologists. Prenatal diagnosis of fetal chromosomal abnormalities[J]. Obstet Gynecol, 2001, 97(5 Pt 1):Suppl 1-12.
  • 4ACOG Committee on Practice Bulletins. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormal- ities[J]. Obstet Gynecol, 2007, 109(1):217-227.
  • 5Lo TK, Lai FK, Leung WC, et al. A new policy for prenatal screening and diagnosis of Down syndrome for pregnant women with advanced maternal age in a public hospital[J]. J Matern Fetal Neonatal Med, 2010, 23(8):914-919.
  • 6Bornstein E, Lenchner E, Donnenfeld A, et al. Advanced maternal age as a sole indication for genetic amniocentesis; risk-benefit analysis based on a large database reflecting the current common practice[J]. J Perinat Med, 2009, 37 (2):99-102.

二级参考文献17

  • 1Herffner LJ. Advanced maternal age-how old is too old ? N Engl J Med, 2004,351 : 1927-1929.
  • 2Dommergues M, Audiberl F, Benanar C, et al. Is routine amniocentesis for advanced maternal age still indicated? Fetal Diagn Ther, 2001,16:372-377.
  • 3Benn PA, Egan JFX, Fang M, et al. Changes in the utilization of prenatal diagnosis. Obstet Gynecol, 2004,103 : 1255-1260.
  • 4Johnson JP, Streets K, Fitzgerald J, et al. Influence of triplemarker screen risk versus a ptiori risk in decision for amniocentesis in women of advanced maternal age. Prenat Diagn, 1998,18:979- 980.
  • 5Hodges RJ, Wallace EM. Testing for Down's syndrome in the older woman : a risky business? Aust N Z J Obstet Gynecol, 2006, 46:370-371.
  • 6Wald N J, Rodeek C, Hackshaw AK, et al. First and Second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS) . Health Techol Assess ,2003,7 : 1-77.
  • 7Wald NJ, Rodeck C, Hackshaw AK, et al. SURUSS in perspective. BJOG,2004, l 11:521-531.
  • 8Malone FD, Canick JA, Ball RH, et al. First-trimester or secondtrimester screening, or both, for Down's syndrome. New Engl J Med, 2005, 353:2001-2011.
  • 9ACOG Practice Bulletin. Clinical management guidelines for obstetfician-gynecolostists. Prenatal diagnosis of fetal chromosomal abnormalities. Obstet Gynecol, 2001,97 : 1-12.
  • 10ACOG Practice Bulletin. Screening for fetal chromosomal abnormalities. Obstet Gynecol,2007, 109:217-227.

共引文献68

同被引文献49

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部